CEO Executive AssistantScaling a health technology company is one of the most demanding leadership experiences in the healthcare industry. The CEO of a health tech company in growth mode faces simultaneous demands across commercial, product, regulatory, talent, and investor dimensions that would challenge any executive team, let alone one that may still be relatively small relative to the ambitions of the business.
In the scaling phase, the time management challenges are distinctly different from those of a mature health system or pharmaceutical company CEO. The organizational infrastructure is incomplete. The processes are still being designed. The team is growing faster than it can be trained. The CEO’s time is simultaneously required for customer-facing commercial work, product vision and oversight, regulatory strategy, talent development, and investor relationships. Every one of these demands can credibly claim to be the CEO’s most important priority in any given week.
Without deliberate time management, health tech CEOs become the organizational bottleneck: the single point through which all decisions must pass, all relationships must be managed, and all strategic work must be done. This bottleneck is fatal to organizational velocity and ultimately to the CEO’s effectiveness and wellbeing.
The Scaling CEO’s Fundamental Time Challenge
The fundamental time management problem for a health tech CEO in the scaling phase is the mismatch between the scope of the role and the organizational infrastructure to support it. At thirty employees, the CEO is still personally managing ten to fifteen distinct organizational functions. At one hundred employees, the organizational chart is taking shape but still has significant coverage gaps. At two hundred employees, the infrastructure is more complete but the CEO’s habits, formed in the earlier stages, often have not adapted to the new organizational reality.
Health tech CEOs who fail to adapt their time management as the organization scales continue to operate as founders, personally involved in every significant activity across the organization, rather than as executives, leading through the organizational structure that their growth is building. This adaptation failure is one of the most common causes of the growth plateau that many scaling health tech companies experience.
Prioritizing the CEO’s Unique Contributions
At every stage of company scaling, the CEO’s time management should be anchored in a clear articulation of their uniquely valuable contributions: the activities that only the CEO can perform effectively and that have the highest impact on organizational outcomes.
For a health tech CEO in the scaling phase, this typically includes: setting and communicating strategic vision, managing the board and investor relationships, closing enterprise customer relationships that require CEO-level engagement, making the organizational design decisions that build the company’s functional leadership infrastructure, and setting the cultural standards that will shape how the company behaves at scale.
What does not belong on this list: managing product development sprints, participating in sales calls that a qualified account executive can handle, attending internal team meetings that your functional leaders can run independently, reviewing routine legal documents that your counsel manages, or handling customer support escalations that a customer success team should own.
Regularly audit your time allocation against this uniquely-valuable-contribution framework. When you find yourself spending time on activities below the CEO threshold, that is your signal to build the organizational capacity that eliminates the need for CEO involvement in that area.
Building the Organizational Infrastructure That Frees CEO Time
The most important time management investment a scaling health tech CEO can make is hiring and developing the functional leaders who will absorb the CEO’s current workload as the organization grows. Every leadership hire that allows the CEO to step back from direct management of a functional area is a time recovery event.
Prioritize leadership hiring based on where you are currently spending the most CEO time on below-threshold work. If you are personally managing every commercial relationship, you need a Head of Sales or Chief Revenue Officer who can own that function. If you are reviewing every product decision, you need a Chief Product Officer who can lead product development without requiring your daily involvement.
This leadership infrastructure investment requires short-term sacrifice. Hiring and developing functional leaders consumes CEO time before it saves it. The leader needs to be recruited, onboarded, equipped with context and authority, and managed through the initial performance variability of any new hire. The payoff comes three to six months later, when a capable leader is running their function independently and the CEO has recovered the time that function previously demanded.
Delegation for hospital CEOs provides delegation frameworks that translate well to the health tech scaling context.
Managing the Investor and Board Dimension
Health tech CEOs at the scaling stage typically manage a board of directors that includes venture capital investors who have specific expectations about CEO engagement, reporting, and strategic communication. This governance relationship is time-intensive and non-negotiable: investors who feel uninformed or misaligned become organizational distractions that consume far more CEO time to manage than a proactive, structured investor communication approach requires.
Build a structured investor communication cadence before you are forced to manage a communication crisis. Monthly written updates to board members, covering key metrics, strategic progress, and emerging challenges, keep investors informed without requiring the CEO to individually manage every investor’s information needs. Quarterly board meetings with substantive agenda design and thorough preparation maintain governance effectiveness without consuming every week’s bandwidth in board management.
Your board relationship also benefits from proactive pre-briefing of significant developments. A board member who learns a major commercial setback, leadership departure, or regulatory challenge in the formal board meeting rather than from a personal CEO conversation before the meeting is a governance partner who feels insufficiently trusted. Pre-brief your board chair on anything significant before it reaches the full board.
Protecting Product and Innovation Time
Health tech companies are driven by product innovation. The CEO’s continued engagement with product vision, not product management details but the strategic direction and user experience principles that make the company’s offering distinctive, is one of the most organizationally important uses of CEO time in a scaling health tech company.
As the company grows, the CEO naturally becomes more distant from the product. A CPO manages the roadmap. Product teams manage the sprints. The CEO’s direct engagement with product development diminishes. This is appropriate in terms of operational involvement, but the CEO should remain closely enough connected to the product experience to maintain their ability to articulate a compelling product vision, identify when the product is drifting from its core differentiation, and make the strategic calls about where the product should go next.
Protect a monthly product deep dive, two to three hours with your CPO and lead product team, where you engage with current development, review user feedback and clinical outcomes data, and discuss the medium-term product direction. This investment ensures that your product vision and the product team’s execution remain in strategic alignment.
According to McKinsey, health tech companies whose executive teams maintain consistent engagement with clinical and user outcomes, rather than focusing exclusively on technical and commercial metrics, build more durable competitive advantages. The CEO’s product engagement is a direct investment in this outcome orientation.
Calendar management for hospital CEOs provides calendar architecture frameworks that adapt well to the health tech scaling context.
Managing Your Own Pace Through the Scaling Sprint
Health tech scaling is a multi-year sprint. The demands do not plateau when you hire the tenth functional leader. They scale with the organization’s ambitions, the competitive environment, and the expectations of investors who have committed capital to significant growth.
Sustainable pace management is therefore not an optional consideration. It is an organizational imperative. A CEO who burns out at the 150-employee mark leaves the company at a critical moment, typically when they are most needed for the next phase of growth. The organizational cost of that departure is enormous.
Protect your minimum sustainable pace: the non-negotiable health and recovery commitments that allow you to perform at the level the scaling organization requires over a multi-year period. Sleep, physical activity, genuine vacation, and personal relationship investment are not indulgences. They are the physiological foundation of the sustained cognitive and emotional performance that scaling leadership demands.
The health tech CEO who masters time management at scale does not work less than their peers. They work differently: more focused, more delegated, more protected in their highest-value activities, and more sustainable in the pace they maintain across the full duration of the scaling journey.
Related Reading
For further context, explore Time Management Strategies for CEOs Leading a Behavioral Health Company and Time Management Strategies for CEOs Managing a Global Healthcare Company.